Prednisolone Tablets B.P. (Vet) 5 mg

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Prednisolone

Available from:

Millpledge Ltd

ATC code:

QH02AB06

INN (International Name):

Prednisolone

Pharmaceutical form:

Tablet

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cats, Dogs

Therapeutic area:

Anti Inflammatory corticosteroid

Authorization status:

Authorized

Authorization date:

1997-08-29

Summary of Product characteristics

Revised: June 2023
AN: 00552/2023
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Prednisolone Tablets B.P. (Vet) 5 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE PER TABLET:
Prednisolone
5mg
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet.
Flat faced, white circular with bevelled edges. One face embossed with
letter P
and reverse face with a scored half break line, embossed with letters
PL above
line and with figure 5 below.
4.
CLINICAL PARTICULARS
4.1. TARGET SPECIES
Dog and cat.
4.2
INDICATIONS FOR USE
As an anti-inflammatory and anti-allergenic agent in either species.
Prednisolone
has found to be useful, often as an adjunct to other agents, in the
treatment of
tumours.
4.3
CONTRA-INDICATIONS
Administration is contra-indicated where corneal ulceration is
present.
Administration is generally contra-indicated if renal disease or
diabetes mellitus is
present.
4.4
SPECIAL WARNINGS
Administration may render concurrent vaccination inoperative.
Revised: June 2023
AN: 00552/2023
Page 2 of 5
4.5
SPECIAL PRECAUTIONS
The lowest effective dose should be used. Treatment should not be
withdrawn
suddenly and in many situations a dosage schedule with falling dose
will be found
of use. Some cases may require continuing therapy, the minimum
effective
maintenance dose should be established.
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
It is generally considered that problems associated with the induction
of adrenal
insufficiency are minimised by dosing once every alternate morning for
dogs and
every alternate evening for cats. Following long or medium term
treatment the
dosage should be reduced gradually.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Impermeable gloves should be worn whilst administering the product.
Take care
to avoid accidental eye contact. If eye contact occurs, wash
thoroughly with clean
running water. Wash hands after use.
4.6
ADVERSE REACTIONS
Prednisolone, as with oth